187 related articles for article (PubMed ID: 23058039)
41. Signal transduction via the B-cell antigen receptor: the role of protein tyrosine kinases and protein tyrosine phosphatases.
Justement LB
Curr Top Microbiol Immunol; 2000; 245(1):1-51. PubMed ID: 10533309
[No Abstract] [Full Text] [Related]
42. A distinct signaling pathway used by the IgG-containing B cell antigen receptor.
Wakabayashi C; Adachi T; Wienands J; Tsubata T
Science; 2002 Dec; 298(5602):2392-5. PubMed ID: 12493916
[TBL] [Abstract][Full Text] [Related]
43. Processing of CD74 by the Intramembrane Protease SPPL2a Is Critical for B Cell Receptor Signaling in Transitional B Cells.
Hüttl S; Kläsener K; Schweizer M; Schneppenheim J; Oberg HH; Kabelitz D; Reth M; Saftig P; Schröder B
J Immunol; 2015 Aug; 195(4):1548-63. PubMed ID: 26157172
[TBL] [Abstract][Full Text] [Related]
44. Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.
Hemon P; Renaudineau Y; Debant M; Le Goux N; Mukherjee S; Brooks W; Mignen O
Clin Rev Allergy Immunol; 2017 Oct; 53(2):141-165. PubMed ID: 28500564
[TBL] [Abstract][Full Text] [Related]
45. BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt.
Juszczynski P; Chen L; O'Donnell E; Polo JM; Ranuncolo SM; Dalla-Favera R; Melnick A; Shipp MA
Blood; 2009 Dec; 114(26):5315-21. PubMed ID: 19855081
[TBL] [Abstract][Full Text] [Related]
46. The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor-mediated signaling.
Mattila PK; Feest C; Depoil D; Treanor B; Montaner B; Otipoby KL; Carter R; Justement LB; Bruckbauer A; Batista FD
Immunity; 2013 Mar; 38(3):461-74. PubMed ID: 23499492
[TBL] [Abstract][Full Text] [Related]
47. CXCR4 signaling and function require the expression of the IgD-class B-cell antigen receptor.
Becker M; Hobeika E; Jumaa H; Reth M; Maity PC
Proc Natl Acad Sci U S A; 2017 May; 114(20):5231-5236. PubMed ID: 28461496
[TBL] [Abstract][Full Text] [Related]
48. Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells.
Lankester AC; van Schijndel GM; van der Schoot CE; van Oers MH; van Noesel CJ; van Lier RA
Blood; 1995 Aug; 86(3):1090-7. PubMed ID: 7620163
[TBL] [Abstract][Full Text] [Related]
49. B-cell tolerance checkpoints in health and autoimmunity.
Meffre E; Wardemann H
Curr Opin Immunol; 2008 Dec; 20(6):632-8. PubMed ID: 18848883
[TBL] [Abstract][Full Text] [Related]
50. Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic Leukemia.
Ten Hacken E; Sivina M; Kim E; O'Brien S; Wierda WG; Ferrajoli A; Estrov Z; Keating MJ; Oellerich T; Scielzo C; Ghia P; Caligaris-Cappio F; Burger JA
J Immunol; 2016 Sep; 197(6):2522-31. PubMed ID: 27534555
[TBL] [Abstract][Full Text] [Related]
51. Histone H2A-Reactive B Cells Are Functionally Anergic in Healthy Mice With Potential to Provide Humoral Protection Against HIV-1.
Agazio A; Cimons J; Shotts KM; Guo K; Santiago ML; Pelanda R; Torres RM
Front Immunol; 2020; 11():1565. PubMed ID: 32849530
[TBL] [Abstract][Full Text] [Related]
52. Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling.
Gauld SB; Benschop RJ; Merrell KT; Cambier JC
Nat Immunol; 2005 Nov; 6(11):1160-7. PubMed ID: 16200069
[TBL] [Abstract][Full Text] [Related]
53. Natural IgM prevents autoimmunity by enforcing B cell central tolerance induction.
Nguyen TT; Elsner RA; Baumgarth N
J Immunol; 2015 Feb; 194(4):1489-502. PubMed ID: 25595791
[TBL] [Abstract][Full Text] [Related]
54. CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand.
Depoil D; Fleire S; Treanor BL; Weber M; Harwood NE; Marchbank KL; Tybulewicz VL; Batista FD
Nat Immunol; 2008 Jan; 9(1):63-72. PubMed ID: 18059271
[TBL] [Abstract][Full Text] [Related]
55. B and T cell tolerance and autoimmunity in autoantibody transgenic mice.
Yan J; Mamula MJ
Int Immunol; 2002 Aug; 14(8):963-71. PubMed ID: 12147633
[TBL] [Abstract][Full Text] [Related]
56. BASH, a novel signaling molecule preferentially expressed in B cells of the bursa of Fabricius.
Goitsuka R; Fujimura Y; Mamada H; Umeda A; Morimura T; Uetsuka K; Doi K; Tsuji S; Kitamura D
J Immunol; 1998 Dec; 161(11):5804-8. PubMed ID: 9834055
[TBL] [Abstract][Full Text] [Related]
57. A role for membrane IgD in the tolerance of pathological human rheumatoid factor B cells.
Soulas P; Koenig-Marrony S; Julien S; Knapp AM; Garaud JC; Pasquali JL; Martin T
Eur J Immunol; 2002 Sep; 32(9):2623-34. PubMed ID: 12207347
[TBL] [Abstract][Full Text] [Related]
58. Multiple paths to loss of anergy and gain of autoimmunity.
Conrad FJ; Rice JS; Cambier JC
Autoimmunity; 2007 Sep; 40(6):418-24. PubMed ID: 17729035
[TBL] [Abstract][Full Text] [Related]
59. Syk-mediated tyrosine phosphorylation is required for the association of hematopoietic lineage cell-specific protein 1 with lipid rafts and B cell antigen receptor signalosome complex.
Hao JJ; Carey GB; Zhan X
J Biol Chem; 2004 Aug; 279(32):33413-20. PubMed ID: 15166239
[TBL] [Abstract][Full Text] [Related]
60. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus.
Iwata S; Yamaoka K; Niiro H; Jabbarzadeh-Tabrizi S; Wang SP; Kondo M; Yoshikawa M; Akashi K; Tanaka Y
Lupus; 2015 Jun; 24(7):695-704. PubMed ID: 25432781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
